| Achemica | Switzerland | Inquire | ||
|---|---|---|---|---|
![]() |
+41 (24) 466-2929 | |||
![]() |
contact@achemica.com | |||
| Chemical manufacturer since 2010 | ||||
| Alfa Chemistry | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (201) 478-8534 | |||
![]() |
inquiry@alfa-chemistry.com | |||
| Chemical distributor since 2012 | ||||
| chemBlink standard supplier since 2012 | ||||
| Array BioPharma Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (303) 381-6600 | |||
![]() |
info@arraybiopharma.com | |||
| Chemical manufacturer | ||||
| Beta Pharma Scientific, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (203) 315-5062 / (877) 786-1922 | |||
![]() |
sales@betapharma.com, | |||
| Chemical manufacturer | ||||
| International Laboratory Limited | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (650) 278-9963 | |||
![]() |
admin@intlab.org | |||
| Chemical manufacturer since 2002 | ||||
| SynQuest Labs, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (386) 462-0788 | |||
![]() |
info@synquestlabs.com | |||
| Chemical manufacturer | ||||
| Zylexa Pharma Ltd. | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (845) 299-6009/ | |||
![]() |
sales@zylexa-pharma.com,enquiries@zylexa-pharma.com | |||
| Chemical manufacturer | ||||
| Name | 1-[3-(4-Chlorophenoxy)Phenyl]Methanamine Hydrochloride (1:1) |
|---|---|
| Synonyms | [3-(4-Chlorophenoxy)Phenyl]Methylamine Hydrochloride; [61343-99-5] |
| Molecular Structure | ![]() |
| Molecular Formula | C13H13Cl2NO |
| Molecular Weight | 270.15 |
| CAS Registry Number | 154108-30-2 |
| SMILES | Cl.Clc2ccc(Oc1cc(CN)ccc1)cc2 |
| InChI | 1S/C13H12ClNO.ClH/c14-11-4-6-12(7-5-11)16-13-3-1-2-10(8-13)9-15;/h1-8H,9,15H2;1H |
| InChIKey | VFEWZXLNJNKEEV-UHFFFAOYSA-N |
| Boiling point | 381.7°C at 760 mmHg (Cal.) |
|---|---|
| Flash point | 184.7°C (Cal.) |
| Refractive index | (Cal.) |
| Safety Description | Irritant |
|---|---|
| Market Analysis Reports |
| List of Reports Available for 1-[3-(4-Chlorophenoxy)Phenyl]Methanamine Hydrochloride (1:1) |